GC-Rise Pharmaceutical Co.
Latest round
- Series B
Last raised
- Sep 2014
Total raised
- $20M
Investors
- 2
About GC-Rise Pharmaceutical Co.
Based in China, GC-Rise Pharmaceutical Co offers pharmaceutical products for anti-aging, reproductive health, gynecologic oncology and autoimmune diseases, dermatology and beauty health, and central nervous system disorders.
Who invested in GC-Rise Pharmaceutical Co.
2 investors across 2 rounds
See all investors in GC-Rise Pharmaceutical Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about GC-Rise Pharmaceutical Co.
Who invested in GC-Rise Pharmaceutical Co.?
GC-Rise Pharmaceutical Co. has 2 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has GC-Rise Pharmaceutical Co. raised?
GC-Rise Pharmaceutical Co. has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did GC-Rise Pharmaceutical Co. last raise money?
GC-Rise Pharmaceutical Co.'s most recent round on record is a Series B, in Sep 2014.
What does GC-Rise Pharmaceutical Co. do?
Based in China, GC-Rise Pharmaceutical Co offers pharmaceutical products for anti-aging, reproductive health, gynecologic oncology and autoimmune diseases, dermatology and beauty health, and central nervous system disorders.
Where is GC-Rise Pharmaceutical Co. headquartered?
GC-Rise Pharmaceutical Co. is headquartered in Beijing, China.
Which VCs invest in companies like GC-Rise Pharmaceutical Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back pharmaceuticals companies at GC-Rise Pharmaceutical Co.'s stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like GC-Rise Pharmaceutical Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.